259 related articles for article (PubMed ID: 37834388)
21. Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes.
Kalejaiye A; Giri N; Brewer CC; Zalewski CK; King KA; Adams CD; Rosenberg PS; Kim HJ; Alter BP
Pediatr Blood Cancer; 2016 Dec; 63(12):2139-2145. PubMed ID: 27428025
[TBL] [Abstract][Full Text] [Related]
22. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita.
Tsilou ET; Giri N; Weinstein S; Mueller C; Savage SA; Alter BP
Ophthalmology; 2010 Mar; 117(3):615-22. PubMed ID: 20022637
[TBL] [Abstract][Full Text] [Related]
23. [Dangerous liaisons: p53, dyskeratosis congenita and Fanconi anemia].
Toufektchan E; Jaber S; Toledo F
Med Sci (Paris); 2017 Jan; 33(1):95-98. PubMed ID: 28120765
[No Abstract] [Full Text] [Related]
24. A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization.
Pereboom TC; van Weele LJ; Bondt A; MacInnes AW
Blood; 2011 Nov; 118(20):5458-65. PubMed ID: 21921046
[TBL] [Abstract][Full Text] [Related]
25. Inherited bone marrow failure syndromes in 2012.
Sakaguchi H; Nakanishi K; Kojima S
Int J Hematol; 2013 Jan; 97(1):20-9. PubMed ID: 23271412
[TBL] [Abstract][Full Text] [Related]
26. Immune status of patients with inherited bone marrow failure syndromes.
Giri N; Alter BP; Penrose K; Falk RT; Pan Y; Savage SA; Williams M; Kemp TJ; Pinto LA
Am J Hematol; 2015 Aug; 90(8):702-8. PubMed ID: 25963299
[TBL] [Abstract][Full Text] [Related]
27. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
[TBL] [Abstract][Full Text] [Related]
28. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.
Ballew BJ; Yeager M; Jacobs K; Giri N; Boland J; Burdett L; Alter BP; Savage SA
Hum Genet; 2013 Apr; 132(4):473-80. PubMed ID: 23329068
[TBL] [Abstract][Full Text] [Related]
29. [New insights into inherited bone marrow failure syndrome].
Ito E; Toki T; Kamio T; Terui K
Rinsho Ketsueki; 2021; 62(10):1455-1464. PubMed ID: 34732617
[TBL] [Abstract][Full Text] [Related]
30. Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
Gramatges MM; Bertuch AA
Transl Res; 2013 Dec; 162(6):353-63. PubMed ID: 23732052
[TBL] [Abstract][Full Text] [Related]
31. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
[TBL] [Abstract][Full Text] [Related]
32. Mutant mice lacking the p53 C-terminal domain model telomere syndromes.
Simeonova I; Jaber S; Draskovic I; Bardot B; Fang M; Bouarich-Bourimi R; Lejour V; Charbonnier L; Soudais C; Bourdon JC; Huerre M; Londono-Vallejo A; Toledo F
Cell Rep; 2013 Jun; 3(6):2046-58. PubMed ID: 23770245
[TBL] [Abstract][Full Text] [Related]
33. Dyskeratosis congenita and telomerase.
Bessler M; Wilson DB; Mason PJ
Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
[TBL] [Abstract][Full Text] [Related]
34. Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes.
Alter BP; Rosenberg PS; Day T; Menzel S; Giri N; Savage SA; Thein SL
Br J Haematol; 2013 Aug; 162(4):542-6. PubMed ID: 23713742
[TBL] [Abstract][Full Text] [Related]
35. De novo TP53 germline activating mutations in two patients with the phenotype mimicking Diamond-Blackfan anemia.
Fedorova D; Ovsyannikova G; Kurnikova M; Pavlova A; Konyukhova T; Pshonkin A; Smetanina N
Pediatr Blood Cancer; 2022 Apr; 69(4):e29558. PubMed ID: 35084091
[TBL] [Abstract][Full Text] [Related]
36. Ribosomal Protein Mutations Result in Constitutive p53 Protein Degradation through Impairment of the AKT Pathway.
Antunes AT; Goos YJ; Pereboom TC; Hermkens D; Wlodarski MW; Da Costa L; MacInnes AW
PLoS Genet; 2015 Jul; 11(7):e1005326. PubMed ID: 26132763
[TBL] [Abstract][Full Text] [Related]
37. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
[TBL] [Abstract][Full Text] [Related]
38. Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing.
Zhang Y; Morimoto K; Danilova N; Zhang B; Lin S
PLoS One; 2012; 7(1):e30188. PubMed ID: 22299032
[TBL] [Abstract][Full Text] [Related]
39. Dyskeratosis congenita as a disorder of telomere maintenance.
Nelson ND; Bertuch AA
Mutat Res; 2012 Feb; 730(1-2):43-51. PubMed ID: 21745483
[TBL] [Abstract][Full Text] [Related]
40. Ribosomal protein deficiency causes Tp53-independent erythropoiesis failure in zebrafish.
Yadav GV; Chakraborty A; Uechi T; Kenmochi N
Int J Biochem Cell Biol; 2014 Apr; 49():1-7. PubMed ID: 24417973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
